Kamal Chemali, MD
- Medical Director, Center for Music and Medicine, UH Cleveland Medical Center
- Director, Autonomic Program and Laboratories, UH Cleveland Medical Center
- Professor of Neurology, CWRU School of Medicine
- Specialty: Neurology
-
Location:UH Cleveland Medical Center Bolwell
11100 Euclid Ave
Cleveland, OH 44106
- Call: 216-844-3192
Biography: Kamal Chemali, MD
Expertise
Certifications & Memberships
- Neurology - American Board of Psychiatry and Neurology
- Electrodiagnostic Medicine, American Board of Electrodiagnostic Medicine
Education
Fellowship | Clinical Neurophysiology
Clinical Neurophysiology - Cleveland Clinic (1999 - 2000)
Residency | Neurology
Neurology - UH Case Medical Center (1996 - 1999)
Internship | Internal Medicine
Internal Medicine - Staten Island University Hospital - North Site (1995 - 1996)
Medical Education
Lebanese University Faculty Of Medical Sciences (1995)
Undergraduate
American University Of Beirut (1987)
About
Kamal Raymond Chémali, MD joined University Hospitals in 2021, almost 22 years after the completion of his neurology residency at University Hospitals. He is the Director of the Autonomic Nervous System Program and the Medical Director of the Music and Medicine Program in the Neurological Institute and a Professor of Neurology at Case Western Reserve University. Dr. Chémali specialized in Neurology at Case Western Reserve University-University Hospitals of Cleveland and sub-specialized in Neuromuscular Diseases, Electromyography and Neurophysiology at the Cleveland Clinic, where he subsequently practiced for twelve years in the Neuromuscular Center. As a Resident at University Hospitals, and as a Fellow and Staff Physician at the Cleveland Clinic, Dr. Chémali became intimately involved in the Autonomic Laboratory and pioneered the use of Infrared Dynamic Pupillometry in the diagnosis of mild and pre-clinical autonomic disorders. He also was heavily involved in Medical Education and took the lead on building the second year neurosciences curriculum at the newly founded Cleveland Clinic Lerner College of Medicine (CCLCM). At CCLCM, he directed the Neuroscience Course Year 2 for six consecutive years. He then moved to Sentara Healthcare in Norfolk, Virginia to found and direct the Sentara Neuromuscular and Autonomic Center that included an AANEM-certified with Exemplary Status EMG Laboratory and a state-of-the-art Autonomic Laboratory. The Center drew referrals from all over the United States and abroad. In Norfolk, Dr. Chémali was also involved in medical and resident education as an Associate Professor of Neurology at Eastern Virginia Medical School.
Dr. Chémali started studying the piano at age seven and continued his musical activities throughout his medical studies and training. Combining his role as a physician and a musician, Dr. Chémali’s firm belief in the power of music in connecting people and in healing disease led him to start the Doctor-Patient Music Connection Program, where physicians and professional or student musicians perform for patients in a hospital setting, and the award-winning Music and the Brain™ Concert-Lectures, educational scientific symposia on the effect of music on the nervous system, incorporating live performances. Along those lines, he was the co-founder of the Cleveland Clinic Arts and Medicine Institute and the Founding Director of the Sentara Music and Medicine Center. An active educator and researcher in the field of music and neuroscience, Dr. Chémali lectures, narrates and participates in lecture-concerts all over the world in concert halls, universities, music festivals and conservatories, in special events that illustrate the important effect of music on health and disease. He has appeared on the stages of prestigious musical institutions such as the Lincoln Center in New York, the Salzburg Music Festival in Austria, The Santa Fe Chamber Music Festival in New Mexico and the Abu Dhabi International Music Festival, among others. On the clinical side, he is a champion of Music Therapy and its applications in neurological disorders.
Nationally, he has been a Head Talk presenter and Course Director at the American Academy of Neurology (AAN) and is the immediate past-Chair of the Autonomic Section of the AAN. Internationally, he currently serves on the advisory boards of international dysautonomia organizations and is a Principal Investigator in industry and NIH–sponsored research.
Research & Publications
Research Interests
Autonomic Disorders, Autonomic Testing, Small Fiber Neuropathies, Music and Medicine, Music Therapy, Neuromuscular Disorders, EMG and Nerve conduction studies
Industry Relationships
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2016, Kamal Chemali did not disclose any Outside Relationships with Industry.